Abstract:Background Cognitive impairment strikingly reduces the quality of life of Parkinson’s disease (PD) patients. Studies find that pathological proteins, neuroinflammatory factors and free radicals may involve in the pathogenesis of cognitive impairment of PD, however, results are inconclusive. Methods We recruited 62 PD patients and 31 healthy controls. PD patients were identified with cognitive impairment, including PD with mild cognitive impairment (PD-MCI) and PD with dementia (PDD) according to the diagnostic criteria for PD-MCI and PDD issued by Movement Disorder Society Task Force. The levels of pathological proteins, including β-amyloid 1–42 (Aβ1-42),Total-tau (T-tau) and phosphorelated tau (P-tau), neuroinflammatory factors,including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interferon-γ (INF-γ) and prostaglandin E 2 (PGE 2 ), free radicals, including hydroxyl radical (·OH), hydrogen peroxide (H 2 O 2 ) and nitric oxide (NO) in cerebrospinal fluid(CSF) were detected. The levels of above factors in CSF were compared among healthy controls and patients with and without cognitive impairment. Correlation analyses were performed between Montreal Cognitive Assessment (MoCA) score and the levels of above factors in CSF. Results T-tau level in CSF from PD-CI patients are significantly elevated comparing with those without cognitive impairment and controls (P = 0.016 and 0.004, respectively). The levels of P-tau (S396) and · OH in PD-CI patients are significantly higher than controls (P = 0.001 and 0.014, respectively). IL-6 levels in PD-CI patients are strikingly enhanced comparing with those without cognitive impairment (P = 0.005). MoCA score is negatively correlated with the levels of T-tau (r = -0.340), P-tau (S396) (r = -0.448), IL-6 (r = -0.489) and · OH (r = -0.504) in PD-CI patients. Conclusions Elevated levels of T-tau, P-tau (S396), IL-6 and · OH in CSF are significantly correlated with cognitive impairment in PD patients. This investigation may suggest the potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment.

Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications

An overview of the relationship between inflammation and cognitive function in humans, molecular pathways and the impact of nutraceuticals

NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Chemokine CCL2 impairs spatial memory and cognition in rats via influencing inflammation, glutamate metabolism and apoptosis-associated genes expression- a potential mechanism for HIV-associated neurocognitive disorder

Convergent Transcriptomic and Genomic Evidence Supporting a Dysregulation of CXCL16 and CCL5 in Alzheimer’s Disease

CCR5 and Inflammatory Storm

Neurotransmitter Receptors and Cognitive Dysfunction in Alzheimer's Disease and Parkinson's Disease

Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency

Chemokines play a role in nerve damage and neuroprotection in vascular dementia

A Complement-Microglial Axis Driving Inhibitory Synapse Related Protein Loss Might Contribute to Systemic Inflammation-Induced Cognitive Impairment.

Inflammatory Role of CCR1 in the Central Nervous System

Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer's Disease

Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research

C-C Motif Chemokine Ligand 2 and Chemokine Receptor 2 in Cardiovascular and Neural Aging and Aging-Related Diseases

Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders

The link between cutaneous inflammation and cognitive impairment

Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study

Neural Network Disturbance in the Medial Prefrontal Cortex Might Contribute to Cognitive Impairments Induced by Neuroinflammation